The University of Bari Aldo Moro is a higher education institution in Bari, Apulia, in Southern Italy. The University of Bari was founded in 1925. It is a state-supported university which is divided into 12 faculties.

During the past decade, Universita' degli Studi di Bari conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universita' degli Studi di Bari" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 5 trials, followed by "Amylyx Pharmaceuticals Inc." with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "Fondazione Melanoma Onlus" with 2 trials sponsored and "Institut für Pharmakologie und Präventive Medizin" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universita' degli Studi di Bari" #1 collaborator was "Edwards Lifesciences" with 2 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials as a collaborator, "Arcispedale S. Anna, Ferrara" with 1 trials as a collaborator, "Azienda Ospedaliera V. Cervello" with 1 trials as a collaborator and "Azienda Ospedaliera, Lucca" with 1 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Universita' degli Studi di Bari" are "Leukemia" (5 trials), "Amyotrophic Lateral Sclerosis" (2 trials), "Aortic Stenosis" (1 trials), "Aortic Valve Stenosis" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Universita' degli Studi di Bari" in a lesser frequency.

Most popular intervention types in "Universita' degli Studi di Bari" are "Drug" (18 trials), "Procedure" (6 trials), "Biological" (5 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AMX0035" (2 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universita' degli Studi di Bari" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Universita' degli Studi di Bari". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Universita' degli Studi di Bari, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universita' degli Studi di Bari, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Universita' degli Studi di Bari has several departments that took part in Clinical trials: "Dept of Emergency and Organ transplantation - University of Bari" - 8 trials, "Department of Biomedical Sciences and Human Oncology - Clinica medica "A. Murri"" - 5 trials, "Policlinico di Bari; Divisione di Nefrologia, Dialisi e Trapianto" - 3 trials, "Department of Biomedical Sciences Human Oncology - Clinica Medica "A. Murri"" - 3 trials, "Renal, Dialysis and Transplant Unit, University of Bari" - 2 trials, "Azienda Ospedaliero-Universitaria Consorziale Pol. di Bari; Neuroscienze e Organi di Senso" - 3 trials